Zurex Pharma, a Madison biotech developing products aimed at preventing infections — in hospitals and at home — has raised $6.2 million in its first major funding round. Baird Venture Partners, Chicago, and the State of Wisconsin Investment Board led the financing. Read full Wisconsin State Journal story here.